Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial.
| Image |  |
|---|---|
| Description | scientific article published on 3 March 2017 |
| Author/s |
author: Bart Neyns Teofila Seremet Vibeke Kruse |
| Publication date | March 4, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |